The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss: How more than a hundred million dollars can go missing. The impact of weight loss drugs on junk food manufacturers. Some ...